Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Renovorx Inc. is active in the Medical Devices & Mechanical Engineering technology area. The company currently has 1 pending office action under review. This prosecution is being handled by 1 distinct examiner and is situated within 1 distinct art unit, indicating a very specific and concentrated focus for the company's current patent efforts.
The busiest examiner for the portfolio is SHAH, NILAY J, who is responsible for the 1 pending office action. As this is the only pending office action for the company, the examiner's findings will be the primary factor in the company's current patenting success. The entire active portfolio is currently dependent on the resolution of this single matter.
The presence of 1 distinct art unit simplifies the prosecution landscape for practitioners. There is no need to manage the varying standards of multiple art units or the different styles of multiple examiners. With 1 distinct examiner and 1 pending office action, the company's current interaction with the patent office is highly focused within the Medical Devices & Mechanical Engineering domain.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHAH, NILAY J | 1 | 76.3% | +46.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18149649 | METHODS FOR DELIVERY OF THERAPEUTIC MATERIALS TO TREAT CANCER | SHAH, NILAY J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18149649 | METHODS FOR DELIVERY OF THERAPEUTIC MATERIALS TO TREAT CANCER | SHAH, NILAY J | — |
| Art Unit | Apps |
|---|---|
| 3783 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18149649 | METHODS FOR DELIVERY OF THERAPEUTIC MATERIALS TO TREAT CANCER | SHAH, NILAY J | 3783 | §103§112 | Final Rejection | — | Pending | Jan 03, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial